Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy.
Saved in:
| Title: | Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy. |
|---|---|
| Authors: | Yin L; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America., Masuyer G; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden., Zhang S; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America., Zhang J; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America., Miyashita SI; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America., Burgin D; Ipsen Bioinnovation, Abingdon, United Kingdom., Lovelock L; Ipsen Bioinnovation, Abingdon, United Kingdom., Coker SF; Ipsen Bioinnovation, Abingdon, United Kingdom., Fu TM; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America., Stenmark P; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.; Department of Experimental Medical Science, Lund University, Lund, Sweden., Dong M; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America. |
| Source: | PLoS biology [PLoS Biol] 2020 Mar 17; Vol. 18 (3), pp. e3000618. Date of Electronic Publication: 2020 Mar 17 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32182233 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yin+L%22">Yin L</searchLink>; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Masuyer+G%22">Masuyer G</searchLink>; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Miyashita+SI%22">Miyashita SI</searchLink>; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Burgin+D%22">Burgin D</searchLink>; Ipsen Bioinnovation, Abingdon, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lovelock+L%22">Lovelock L</searchLink>; Ipsen Bioinnovation, Abingdon, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coker+SF%22">Coker SF</searchLink>; Ipsen Bioinnovation, Abingdon, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fu+TM%22">Fu TM</searchLink>; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Stenmark+P%22">Stenmark P</searchLink>; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.; Department of Experimental Medical Science, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Dong+M%22">Dong M</searchLink>; Department of Urology, Boston Children's Hospital, Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101183755%22">PLoS biology</searchLink> [PLoS Biol] 2020 Mar 17; Vol. 18 (3), pp. e3000618. <i>Date of Electronic Publication: </i>2020 Mar 17 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101183755 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-7885 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215449173%22">15449173 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32182233 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pbio.3000618 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e3000618 Titles: – TitleFull: Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yin L – PersonEntity: Name: NameFull: Masuyer G – PersonEntity: Name: NameFull: Zhang S – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Miyashita SI – PersonEntity: Name: NameFull: Burgin D – PersonEntity: Name: NameFull: Lovelock L – PersonEntity: Name: NameFull: Coker SF – PersonEntity: Name: NameFull: Fu TM – PersonEntity: Name: NameFull: Stenmark P – PersonEntity: Name: NameFull: Dong M IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 03 Text: 2020 Mar 17 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1545-7885 Numbering: – Type: volume Value: 18 – Type: issue Value: 3 Titles: – TitleFull: PLoS biology Type: main |
| ResultId | 1 |